cervical persistent high-risk HPV infection
Conditions
Interventions
Controlled group:interferon
Sponsors
The Three Gorges Hospital Affiliated to Chongqing University
Eligibility
Sex/Gender
Female
Age
21 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Women aged 21-65 years old with sexual history; 2. Patients with high-risk human papillomavirus (HPV) infection confirmed by cervical HPV-DNA examination, and with a 6-month history of infection with at least one high-risk HPV subtype; 3. Patients willing to provide written informed consent, or whose legally authorized guardian is able to provide written informed consent.
Exclusion criteria
Exclusion criteria: 1. Women during pregnancy and lactation; 2. Has received cervical physiotherapy or cervical surgery in the past 1year; 3. Colposcopy suggested the type 3 transformation area 4.Complicated with vulvovaginal squamous intraepithelial lesions or other reproductive diseases that require immediate treatment; 5. Diabetes patients with severe heart, brain, respiratory diseases, liver and kidney insufficiency, coagulation dysfunction, severe anemia, or no drug ability to control; 6. People with syphilis, AIDS (AIDS), or other sexually transmitted diseases; 7. Cervical histopathological examination of cervical intraepithelial neoplasia 3,endocervical curettage (ECC) was positive; 8. The investigator is not fit to attend this clinical investigator for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall effective of cervical high-risk HPV clearance; | — |
Secondary
| Measure | Time frame |
|---|---|
| Vaginal bleeding;Vaginal fluid;pain; | — |
Countries
China
Contacts
Public ContactShihua Mao
The Three Gorges Hospital Affiliated to Chongqing University
Outcome results
None listed